Altium Capital Management LP - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$11,718,100
+66.0%
305,0000.0%8.87%
+126.3%
Q1 2023$7,060,750
-30.0%
305,000
-20.8%
3.92%
-23.5%
Q4 2022$10,087,000
-2.3%
385,000
-26.7%
5.13%
+35.5%
Q3 2022$10,322,000
-4.0%
525,000
-14.6%
3.78%
-12.1%
Q2 2022$10,756,000
+20.6%
615,000
+12.8%
4.30%
+44.2%
Q1 2022$8,916,000
+0.3%
545,0000.0%2.98%
+21.7%
Q4 2021$8,889,000
+49.8%
545,000
+17.2%
2.45%
+57.5%
Q3 2021$5,933,000
+0.9%
465,000
+11.6%
1.56%
+14.1%
Q2 2021$5,882,000
+83.9%
416,567
+102.4%
1.36%
+53.6%
Q1 2021$3,198,000
-2.0%
205,7990.0%0.89%
-27.2%
Q4 2020$3,264,000205,7991.22%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders